Skip to Main Content

Paper Details

Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [<sup>64</sup>Cu]Cu-NOTA-panitumumab F(ab')<sub>2</sub> alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib.
Nucl Med Biol
4
2020
Author NameAffiliation
David W HedleyPrincess Margaret Cancer Centre, University Health Network
  • 1 - 1

Datasets

Release 1.2